Visualitzant O - Articles científics per títol

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer

Gonzalez, David; Mateo Valderrama, Joaquim; Stenzinger, Albrecht; Rojo, Federico; Shiller, Michelle; Wyatt, Alexander W (Wiley, 2021-07)

Pralsetinib in patients with RET fusion–positive non-small-cell lung cancer: A plain language summary of the ARROW study

Griesinger, Frank; Baik, Christina; Tan, Daniel; Lee, Dae Ho; Curigliano, Giuseppe; Subbiah, Vivek; GARRALDA, Elena (Future Medicine, 2024-02)

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Rosas , Juan Camilo; Aguado-Barrera, Miguel E; Briers, Erik; Elliott, Rebecca; Farcy-Jacquet, Marie-Pierre; Giraldo Marin, Alexandra; Azria, David; Gutiérrez-Enríquez, Sara; Reyes López, Victoria (Wiley, 2023-11-01)

Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma

Garcia Ruiz, Alonso; Naval‑Baudin, Pablo; Pons‑Escoda, Albert; Bruna, Jordi; Plans, Gerard; Pérez López, Raquel; Ligero, Marta (Nature Research, 2021-01-12)

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

Muik, Alexander; Garralda Cabanas, Elena; Altintas, Isil; Gieseke, Friederike; Geva, Ravit; Ben-Ami, Eytan; Alonso-Casal, Guzman (American Association for Cancer Research, 2022-05-01)

Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer

Fisher, Virginia; Mateo Valderrama, Joaquim; Gjoerup, Ole V.; Madison, Russell W.; Graf, Ryon; Raskina, Kira (Elsevier, 2022-01)

Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab

Ligorio, Francesca; Di Cosimo, Serena; verderio, paolo; ciniselli, chiara maura; Pizzamiglio, Sara; Castagnoli, Lorenzo; Nuciforo, Paolo (Oxford University Press, 2022-12)

Presence of Ceramidase Activity in Electronegative LDL

Puig Calvó, Núria; Rives, Jose; Estruch Alrich, Montserrat; Aguilera-Simón, Ana; Rotllan, Noemi; Camacho, Mercedes; Colome Calls, Núria; Canals Suris, Francesc (MDPI, 2022-12-22)

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe

Pinato, David J.; Lee, Alvin J. X.; Biello, Federica; Seguí, Elia; Aguilar Company, Juan; Ruiz Camps, Isabel; Tabernero Caturla, Josep; Carbó, Anna (MDPI, 2020-07-08)

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

Casarrubios García, Marta; Cruz-Bermúdez, Alberto; Martínez Marti, Alexandre; Martínez Marti, Alexandre; Insa, Amelia; Nadal, Ernest; Lázaro, Martín; Garcia Campelo, Rosario (American Association for Cancer Research, 2021-11-01)

Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

Romey, Marcel; Llort, Gemma; Torres-Esquius, Sara; Llop-Guevara, Alba; Gutiérrez-Enríquez, Sara; Teule, Alex; Serra, Violeta; Balmaña, Judith (American Medical Association, 2024-04-01)

Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

Llombart Cussac, Antonio; Pérez-García, Jose Manuel; Ruiz Borrego, Manuel; Blanch, Salvador; Fernández-Ortega, Adela; Tolosa, Pablo; Saura Manich, Cristina (Elsevier, 2024-04-11)

Prevention and management of secondary central nervous system lymphoma

Bobillo Varela, Sabela; Khwaja, Jahanzaib; Ferreri, Andrés J. M.; Cwynarski, Kate (Ferrata Storti Foundation, 2023-03)

Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy

Reinisch, Mattea; Bruzas, Simona; Gluz, Oleg; Ataseven, Beyhan; Schmid, Peter; Cortes, Javier (Wiley, 2023-06)

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials

Fernandez-Martinez, Aranzazu; Pascual, Tomás; Singh, Baljit; Nuciforo, Paolo; Rashid, Naim U.; Ballman, Karla (American Medical Association, 2023-04)

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

Villacampa Javierre, Guillermo; Pascual, Tomás; Brasó Maristany, Fara; Paré, Laia; Martínez-Sáez, Olga; Cortes, Javier (Elsevier, 2024-03-04)

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

Grenader, Tal; Pavel, Marianne E.; Ruszniewski, Philippe B.; Ćwikła, Jarosław B.; Phan, Alexandria T.; Raderer, Markus; Capdevila Castillon, Jaume (Wolters Kluwer Health, 2020-03)

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

Bobillo Varela, Sabela; Joffe, Erel; Sermer, David; Mondello, Patrizia; Ghione, Paola; Caron, Philip C. (Springer Nature, 2021-06-16)

Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice

Ovejero Romero, Pablo; Arribas López, Joaquin Vicente; Arenas Lahuerta, Enrique Javier; Martínez-Sabadell, Alex (Cell Press, 2022-12-16)

pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation

Boix Sanchez, Olga; Martinez Pascale, Marion; Vidal, Santiago; Gimenez Alejandre, Marta; Palenzuela Diaz, Lluís; Lorenzo-Sanz, Laura; Moscoso, Olivier; Ciriaco Cortés, Nikaoly; Nuciforo, Paolo Giovanni; Tian, Tian V; Vivancos Prellezo, Ana; Ramon y Cajal Agüeras, Santiago; Abad Mendez, Maria (Nature Portfolio, 2022-11-11)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer

Pralsetinib in patients with RET fusion–positive non-small-cell lung cancer: A plain language summary of the ARROW study

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer

Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab

Presence of Ceramidase Activity in Electronegative LDL

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

Prevention and management of secondary central nervous system lymphoma

Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice

pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer ﻿

Pralsetinib in patients with RET fusion–positive non-small-cell lung cancer: A plain language summary of the ARROW study ﻿

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer ﻿

Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma ﻿

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors ﻿

Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer ﻿

Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab ﻿

Presence of Ceramidase Activity in Electronegative LDL ﻿

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe ﻿

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy ﻿

Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer ﻿

Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial ﻿

Prevention and management of secondary central nervous system lymphoma ﻿

Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy ﻿

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials ﻿

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B) ﻿

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors ﻿

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse ﻿

Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice ﻿

pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer

Pralsetinib in patients with RET fusion–positive non-small-cell lung cancer: A plain language summary of the ARROW study

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer

Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab

Presence of Ceramidase Activity in Electronegative LDL

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

Prevention and management of secondary central nervous system lymphoma

Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice

pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation